
Adipotide
Adipocyte-targeting cytotoxic.
- Sizes available
- 5mg
- Lab certificate (COA)
- Arrives with shipment
· Research-grade only · Not for human consumption · 21+ ·
Vascular-targeted fat apoptosis. Body fat research (animal stage).
Mechanism · FK16 / KLA targeting peptide. Adipocyte vasculature pro-apoptotic. Animal trials.
Best for. Not for.
Best for
- Pre-clinical adipocyte vasculature ablation research framing
- Users interested in the original Arap and Pasqualini MD Anderson mechanism
Not for
- Anyone attempting human use; primate trials show renal toxicity
- Personal or family history of renal impairment
- Pregnancy / pregnancy
- FDA / EMA approval not established. 100% animal research
- Self-administered weight-loss attempts (HIGH RISK)
Mechanism, dose, ramp, risk.
- Mechanism
- Vascular-targeted peptide that ablates fat tissue blood supply.Source · PEPVERA editorial
- Target dose
- Research-only.Source · PEPVERA editorial
- Ramp
- Pre-clinical.Source · PEPVERA editorial
- Risks
- Renal toxicity in trials.Source · PEPVERA editorial
Compared to its siblings.
Adipotide
Vascular-targeted fat apoptosis. Body fat research (animal stage).
Pros
- · Vascular-targeted adipocyte ablation mechanism distinct from GLP-1 pathway compounds.
- · Not yet FDA filed, similar to retatrutide's pre-approval status.
Cons
- · No FDA approval; tirzepatide carries Mounjaro 2022 label and large evidence base.
- · Animal stage only with renal-tox signal, versus retatrutide's Phase 3 TRIUMPH data.
- · No human clinical dataset.
Tirzepatide
FDA-approved alternative. GLP-1 / GIP dual.
Pros
- · FDA Mounjaro 2022
- · Large evidence base
Cons
- · Injection burden
See Tirzepatide →
Retatrutide
GLP-1 / GIP / glucagon triple. Strong Phase 3 results.
Pros
- · TRIUMPH Phase 3
Cons
- · Not yet FDA
See Retatrutide →
COA per supplier
Published, in-house, or shipment-time
Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.
Compare 1 suppliers
| Supplier | Price | COA | Ships | |
|---|---|---|---|---|
| Pure Peptide UKUK | $52.8$10.56/mg · 5mg | In-house COA | 4 days | Out of stock |
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Week 1–2
Research-only.
Initiation
Week 3–4
Research-only.
Signal emerges
Week 5–8
Research-only.
Hold
Week 9–12
Cycle review
Assess
Draw 20 units.
1 mg = 0.20 mL at 5.00 mg/mL. 10.0 doses per vial.
niche · VIII
Adipotide · 10mg